A Very Rare Case of Pancreatic Acinar Variant of Gastric Adenocarcinoma with Review of the Literature

A pancreatic acinar variant of gastric adenocarcinoma is a very rare presentation, and only six cases have been reported worldwide.A 55-year-old male came with complaints of vomiting and weight loss. By PET-CT, a growth was found in the gastric antrum.Distal gastrectomy was done and a histopathology report of a pancreatic acinar variant of gastric adenocarcinoma was done.

Evaluation of efficacy and safety profile of tamsulosin in benign prostatic hyperplasia

Background: To evaluate the efficacy and safety profile of alpha-1A receptor subtype specific antagonist-tamsulosin in benign prostatic hyperplasia.Methods: An open label, non-randomised, prospective, single centred study who were visiting urology department with confirmed diagnosis of benign prostatic hyperplasia (BPH) were included in the study. Thirty patients with BPH were prescribed tamsulosin and were followed up to three months. The initial or baseline data collected were identification of the patients such as international prostate symptom score (IPSS), prostate specific antigen, urine analysis, and ultrasonography of prostate including post void residual urine. The patients were followed up to 3 months to measure clinical and laboratory outcomes (IPSS score, post void residual urine, uroflow rates etc.).Results: In our study, patients receiving tamsulosin 0.4 mg once daily showed a significant improvement in post-void residual urine (PVRU), uroflow rates and IPSS score. The improvements in the above parameters were found to be statistically insignificant at first and third month of follow-up.Conclusions: In our study, tamsulosin an alpha-1A receptor subtype specific antagonist showed significant improvement in BPH symptoms and the drug was well tolerated.

Approaches to a posterior polar cataract inside-out delineation and strategies for emulsification

Management of a posterior polar cataract poses a special challenge to the cataract surgeon because of its predisposition to posterior capsule dehiscence during surgery. The following principles help guide the surgeon during the procedure. Preoperatively the patient has to be counseled thoroughly regarding the possibility of drop nucleus. A thorough preoperative evaluation is mandatory to look for an associated posterior capsule defect. The surgical technique should include the following steps: Maintain a closed chamber at all times, perform an adequate-sized anterior capsulorhexis, avoid hydrodissection - instead perform Inside-Out Hydrodelinearion, during nucleus emulsification use low fluid parameters and follow the principles of slow motion technique and step down technique. Inject OVD before removing any instrument from the eye. In case of a posterior capsule dehiscence, try to convert the dehiscence into a posterior capsulorhexis. Inject Viscoat over the area of dehiscence and perform adequate 2-port automated anterior vitrectomy. In case of a posterior capsule dehiscence implant IOL in the bag only if a complete posterior capsulorhexis is achieved